Director, Scientific Communications & Medical Publications

Johnson & Johnson Co.; Raritan (NJ); Hybrid; USD 164,000 - 283,000; Full time

Job summary

Johnson & Johnson in Raritan, NJ, is seeking a Director of Scientific Communications, Content and Publications. This hybrid role leads strategic scientific communications for Milvexian, oversees medical content and publication plans, and guides training and alliance collaboration.

We require 8–10 years in medical/pharma settings, with 5+ years in scientific communications, and a global, cross-functional mindset. Travel up to 20% is anticipated.

Qualifications

• 8–10 years in medical, clinical, scientific, or pharmaceutical environments.
• 5+ years in pharmaceutical scientific communications.
• Subject-matter expertise in Medical Affairs strategy, scientific communications, content, and publications.
• Strong collaboration, matrix management, and influencing skills.
• Global, cross-regional partnership experience.
• Willingness to travel up to 20% domestically and internationally.

Responsibilities

• Develop strategic scientific communication materials and core assets.
• Lead global and regional medical content plans and onboarding materials.
• Develop, update, and execute global and regional publication plans.
• Ensure compliance with regulatory guidelines for all activities.
• Manage budgets and financial activities in line with strategic plans.

Skills

Collaboration

Matrix management

Communication skills

Strategic thinking

Project management

Influencing

Global mindset

Budget management

Travel readiness

Education

Education: Bachelor/Master/MD/PhD/MBA

Job description

Johnson & Johnson in Raritan, NJ, is seeking a Director of Scientific Communications, Content and Publications. This hybrid role leads strategic scientific communications for Milvexian, oversees medical content and publication plans, and guides training and alliance collaboration.

We require 8–10 years in medical/pharma settings, with 5+ years in scientific communications, and a global, cross-functional mindset. Travel up to 20% is anticipated.